Bristol-Myers Squibb Symposium
Noyes 153 (J. Holmes Sturdivant Lecture Hall)
Pharmaceutical Process Chemistry at Bristol-Myers Squibb and the Preparation of Brivanib Alaninate
Jaan Pesti,
Dr.,
Early Phase Research & Development,
Bristol-Myers Squibb,
An introduction to the practice of process chemistry with further insights to its manifestation in pharmaceutical chemistry at BMS. The process development of a potential oncology drug, brivanib alaninate, will be described.
For more information, please contact Arleen (Lynne) Martinez by phone at 4004 or by email at [email protected].